BackAimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 Overview
Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 Return on Equity

Latest ROE for Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028: -9.2% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

-9.20%

Return on Equity

-9.20%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 (AFJKR) FAQ

The latest ROE for AFJKR is -9.2%. That is below the sector sector average of -5.84%. Investors often review this figure alongside Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, AFJKR currently prints -9.2% for ROE, while the sector average sits near -5.84%. That is roughly 57.3% below the sector mean. Large gaps often invite a closer look at Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028's growth, margins, and balance sheet.

Return on Equity shows how effectively Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 converts resources into returns. At -9.2%, AFJKR may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting AFJKR's ROE (-9.2%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.